News & Partnering

Press releases

Year

April 17, 2023

Imvax Presents New Data at AACR 2023 Supporting the Mechanism of Action of its Lead Program, IGV-001, for Glioblastoma

March 27, 2023

Imvax Announces First Patient Dosed in Phase 2b Trial of IGV-001 for Glioblastoma

November 10, 2022

Imvax Presents Preclinical Data at SITC 2022 Supporting Mechanism of Action and Anti-tumor Activity of its Immunotherapy Platform Across Multiple Tumor Types

October 6, 2022

Imvax to Present New Data on Tumor-Derived Immunotherapy Platform at 2022 SITC Meeting

In the News

Year

April 21, 2023 | Local 12 - WKRC

University of Cincinnati researchers helping develop ‘vaccine’ to fight aggressive cancer

March 30, 2023 | BioBuzz

Imvax Charges Ahead with Phase IIb Glioblastoma Trial

Upcoming Events

None at this time, stay tuned!